That said, when we attempt to pharmacologically interfere with, preserve, or augment the bodys innate physiological processes, there are bound to be side effects and adverse events
Diabetic retinopathy or active retinal disease
Conclusions The present review goes so far as to suggest that GLP-1 medicines represent a watershed moment in treating chronic diseases, with their therapeutic reach extending well beyond their creators' expectations
This article examines the rationale, risks, and alternatives for managing digestive symptoms during GLP-1 therapy
Glucagon-like peptide-1 (GLP-1) analogues are a class of drugs primarily used in the treatment of type 2 diabetes and obesity
It should be noted that while GLP-1 agonists positively impact metabolism upstream of the liver, this may not subsequently improve the fibrotic liver injury within the tested treatment duration